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Host-associated microbes form an important component of immunity that protect
against infection by pathogens. Treating wild individuals with these protective microbes,
known as probiotics, can reduce rates of infection and disease in both wild and captive
settings. However, the utility of probiotics for tackling wildlife disease requires that
they offer consistent protection across the broad genomic variation of the pathogen
that hosts can encounter in natural settings. Here we develop multi-isolate probiotic
consortia with the aim of effecting broad-spectrum inhibition of growth of the lethal
amphibian pathogen Batrachochytrium dendrobatidis (Bd) when tested against nine
Bd isolates from two distinct lineages. Though we achieved strong growth inhibition
between 70 and 100% for seven Bd isolates, two isolates appeared consistently
resistant to inhibition, irrespective of probiotic strategy employed. We found no evidence
that genomic relatedness of the chytrid predicted similarity of inhibition scores, nor that
increasing the genetic diversity of the bacterial consortia could offer stronger inhibition
of pathogen growth, even for the two resistant isolates. Our findings have important
consequences for the application of probiotics to mitigate wildlife diseases in the face of
extensive pathogen genomic variation.
Keywords: chytrid fungus, Batrachochytrium dendrobatidis, wildlife disease, amphibian decline, amphibian
disease
INTRODUCTION
Emerging infectious diseases pose a significant threat to human and wildlife health, and are
responsible for driving declines in biodiversity around the globe (Jones et al., 2008; Tompkins
et al., 2015; Scheele et al., 2019). The last few decades alone have witnessed the emergence and
spread of multiple viral and fungal pathogens capable of infecting a broad range of host species, and
developing strategies to mitigate the loss of wildlife species caused by disease is now a key priority.
The use of probiotics, where hosts are exposed to microbes with known host-protective properties,
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represent a promising tool for tackling infectious disease
(McKenzie et al., 2018). To date, probiotics have been applied
in the fields of human medicine (Kerry et al., 2018), wildlife
medicine (Kueneman et al., 2016), aquaculture (Tan et al.,
2016) and both arable (Marcano et al., 2016) and livestock
(Mingmongkolchai and Panbangred, 2018) agriculture, with
varying success. Developing e ective probiotics is complicated
by the fact that distinct lineages of a pathogen exhibit markedly
di erent susceptibilities to the same bacterial assemblages
(Antwis et al., 2015; Antwis and Weldon, 2017; Muletz-Wolz
et al., 2017; Antwis and Harrison, 2018). A bacterial probiotic
that is inhibitory for one variant of a pathogen can promote
growth of a di erent variant (e.g., Antwis and Harrison, 2018).
Therefore, probiotics comprising single bacterial species appear
unlikely to be provide a “silver bullet” capable of inhibition across
the broad spectrum of pathogen variants observed in natural
systems. This issue is exacerbated by the propensity of pathogen
genotypes to spread rapidly around the globe, often as a result
of human activity (O’Hanlon et al., 2018), exposing susceptible
hosts to multiple and novel threats (Greenspan et al., 2018; Longo
et al., 2019). Therefore, designing novel probiotic strategies that
are e ective against the full panorama of pathogen genotypes is
necessary in order to e ect meaningful change in the rates of
infection caused by emerging infectious diseases.
Recent evidence suggests that the shortcomings of single
species probiotics can be overcome by administering multiple
bacterial isolates in a mixed community, referred to as a
consortium (e.g., Piovia-Scott et al., 2017; Antwis and Harrison,
2018). However, quantitative estimates of the ability of multi-
species consortia to elicit wide-spectrum inhibition of wildlife
pathogens is scarce. Here, we test the ability of multi-
isolate bacterial consortia to inhibit isolates of the chytrid
fungus Batrachochytrium dendrobatidis (Bd), which causes the
lethal disease chytridiomycosis in amphibians (Lips, 2016).
Chytridiomycosis has resulted in the decline of over 500
amphibian species of the last 50 years (Scheele et al., 2019), and
remains a major threat to amphibian biodiversity around the
globe (Lips, 2016; O’Hanlon et al., 2018; Scheele et al., 2019).
Application of bacterial probiotics can reduce the growth of Bd
in vitro (Antwis et al., 2015; Muletz-Wolz et al., 2017; Piovia-
Scott et al., 2017; Antwis and Harrison, 2018) and reduce Bd-
associated mortality in vivo (Kueneman et al., 2016). Previous
work has highlighted that constructing probiotic consortia that
maximize the genetic distance among bacterial isolates elicits
stronger inhibition against Bd than consortia containing the same
number of more closely related isolates (Antwis and Harrison,
2018). These data suggest that the emergent functional properties
of a probiotic consortium, in this case pathogen inhibition,
may be a function of overall genetic diversity rather than
species diversity (Piovia-Scott et al., 2017) and resonates with
biodiversity-function relationships studies in macroecology (e.g.,
Brophy et al., 2017, see also Koskella et al., 2017). Maximizing
intra-consortium genetic diversity may therefore increase the
probability of obtaining broad-spectrum inhibition across a
diverse suite of pathogen genotypes and minimize the impact
of lethal wildlife diseases. Moreover, selecting bacteria that
exhibit strong inhibitory capabilities individually may maximize
the potential for broad-spectrum inhibition across pathogen
genotypes when combined in a consortium.
Here we examine patterns of inhibition of both individual
bacterial isolates and consortia tested against a panel of nine
isolates of Bd (Table 1), comprising eight isolates of the highly
virulent Global Panzootic Lineage (BdGPL) and one isolate of
the more distantly related BdCAPE (see O’Hanlon et al., 2018).
We seek to test the following predictions: (i) Bd isolates will
vary in their susceptibility to inhibition by individual bacterial
isolates, but using bacterial consortia will reduce the among-
isolate variation in inhibition; (ii) probiotic consortia with higher
mean genetic diversity will more likely elicit broad-spectrum
inhibition of multiple pathogen variants; and (iii) Bd isolates that
are more genetically similar will have more similar inhibition
profiles across the panel of isolates tested.
MATERIALS AND METHODS
Isolation of Bacteria and Probiotic
Design
We isolated bacteria from the skin of wild Agalychnis spp.
frogs at Las Cuevas Research Station in the Maya Mountains
of Belize by permission of the Belize Forestry Department
(Research and Export Permit Number CD/60/3/12; Antwis
et al., 2015). Briefly, we swabbed frogs and streaked these
out on R2A agar. Bacteria were left to grow at ambient
temperature for eight days, and we picked individual colonies
using sterile swabs, which were stored in R2A media and
shipped to the United Kingdom (DEFRA Authorization Number
TARP/2012/224). We confirmed purity of bacteria by re-
streaking on R2A and used colony PCR to amplify the 16S
rRNA gene (with primers 27F and 1492R), which were sequenced
at the University of Manchester. We aligned the forward and
reverse sequences for each bacterium and blasted these against
the NCBI database1 to identify bacteria. We maintained frozen
stocks of pure bacteria stored in 30% glycerol and 70% tryptone
solution at  80 C, which were used for subsequent in vitro
challenge assays.
For in vitro challenge assays, we used three bacteria from
each of four genera (Acinetobacter spp., Chryseobacterium spp.,
Serratia spp., and Stentrophomonas spp.) based on preliminary
screening of inhibitory capabilities; medium to strong inhibitors
pf Bd’s growth were selected to maximize the potential inhibitory
capabilities of consortia (Supplementary Table S1). We added
50 µl of the 12 bacteria (three cultures per bacterial strain) to
15 ml of 1% tryptone and incubated these at 18 C for 36 h
until turbid. We did not adjust cell density prior to inhibition
to avoid altering the metabolite profiles already produced by
cultures through the addition of media.
Challenge Assays
For each probiotic, we added bacteria to 12 ml of fresh
1% tryptone broth and left these to incubate for 4 h.
A total of 3 ml of bacteria were used for each probiotic,
1http://blast.ncbi.nlm.nih.gov/Blast.cgi
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TABLE 1 | Batrachochytrium dendrobatidis (Bd) strain information for nine isolates used in this study, comprising eight isolates of BdGPL, and one of BdCAPE.
Isolate Lineage Geographic location Host species Collector Year
CORN2.3 GPL Penhale Farm, Cornwall, United Kingdom Ichthyosaurus alpestris Trenton Garner 2012
IA2011 GPL Ibon Acherito, Spain Alytes obstetricans Matthew Fisher 2011
IA42 GPL Ibon Acherito, Spain Alytes obstetricans Trenton Garner 2004
JEL423 GPL Guabal, Panama Agalychnis lemur Joyce Longcore 2004
MG04 GPL Silver Mine, Western Cape, South Africa Amietia fuscigula Trenton Garner 2010
MG09 GPL Magoebaskloof, Limpopo, South Africa Hadromophryne natalensis Che Weldon 2008
MODS 28.1 GPL Mont Olia, Sardinia, Italy Discoglossus sardus Trenton Garner 2010
SA4c CAPE Pinetown, KwaZulu Natal, South Africa Amietia angolensis Trenton Garner 2010
SFBC019 GPL Sellafield, Cumbria, United Kingdom Epidalea calamita Peter Minting 2010
split evenly between the number of bacteria added to
each group; either one (“single probiotic”), two (“double
probiotic”), or three (“triple probiotic”). Double probiotics were
always constructed from two unique congeneric bacterial
isolates. Triple probiotics were constructed from three
bacteria either within the same genus (“inter-genera triple
probiotic,” total of four mixes) or across three di erent
genera (“intra-genus triple probiotic,” total of four mixes;
Supplementary Table S1).
Nine Bd isolates were used for in vitro challenges, isolated
from a range of host species from Europe, Africa and
Central America (Table 1; see Bd Sequencing below for
additional information). These were grown in 1% tryptone broth
until maximum zoospore production was observed (⇠3 days;
⇠1 ⇥ 106 zoospores ml 1). Three flasks per Bd isolate were
grown and combined for in vitro challenges. Bd zoospores were
separated from sporangia by filtering through 20 µl sterile
filters (Millipore, Ireland). Bacterial probiotics were filtered
(0.22 µm sterile filter; Millipore, Ireland) to isolate bacterial
products in the filtrate, which were kept on ice until Bd
challenges were conducted.
To conduct the in vitro challenge assays, 50 µl of bacterial
filtrate and 50 µl of Bd suspension were combined in 96-well
plates. Each Bd -bacteria combination was run in triplicate.
Positive controls were included using 50 µl 1% tryptone instead
of bacterial filtrate. Negative controls were included using
50 µl sterile tryptone and 50 µl of heat-treated Bd for each
isolate. The optical density (OD) was measured at 492 nm
filter on a spectrophotometer on initial construction of the
challenge assays, and every 24 h after for four subsequent
days. For each measurement, data were transformed using the
equation Ln[OD/(1-OD)], and a regression analysis was used
to gain the slope values for each sample over time (Antwis
and Harrison, 2018). The slopes of the three replicates for each
Bd-bacteria combination were averaged, and the slope of the
negative controls subtracted. Total Bd inhibition was calculated
using the formula: Inhibition (%) = [1 (slope of sample/slope
of control)] ⇥ 100 to give an “inhibition score.” A positive
inhibition score represents inhibition of Bd growth and a negative
score indicates enhanced growth of Bd. We did not use a nutrient
depleted control in our experiments (Bell et al., 2013), which
means Bd inhibition relative to the controls may be slightly
under-estimated.
Bd Sequencing
Extracted high molecular weight DNA of six Bd isolates were
sequenced on an Illumina HiSeqTM platform (Illumina, CA,
United States), which produced 125 + 125 bp paired-end
sequenced reads using the Illumina HiSeqTM high output
V4 chemistry. Data analysis was done using a previously
defined Bd specific alignment pipeline and stringent variant
discovery conditions (O’Hanlon et al., 2018). A pairwise Bd
relatedness matrix was generated in R by comparing genotype
calls across all segregating sites in the isolate collection (185290
segregating sites).
Statistical Analysis
All statistical analyses, code and data files are provided
as a supplementary R Markdown document to allow full
reproducibility of results. All statistical analyses were conducted
in the software R v.3.5.3 (R Core Team, 2019). We used the
Bayesian mixed e ects modeling package brms (Bürkner, 2017,
2018) to fit statistical models. We assessed convergence of models
based on R-hat values, and visually inspected chains to ensure
adequate mixing. We used an information criterion based on
leave-one-out cross validation (LOO-IC; Vehtari et al., 2017),
calculated by the loo package (Vehtari et al., 2019) called via
brms to select among candidate models, and present mean
parameter estimates of e ects and 95% credible intervals as
appropriate. LOO-IC values presented represent comparison
to the null model.
Patterns of Inhibition Across Consortium Types and Bd
Isolates: To examine the e ects of probiotic type (single isolate,
double isolate, etc.), Bd isolate and bacterial genus on inhibition
scores, we fitted a linear mixed e ects model (LMM) with
inhibition as the response, probiotic type as a fixed e ect, and
Bd isolate and bacterial genus as random intercepts. As the
dataset contained both positive and negative inhibition values,
where a negative value represents facilitation of Bd growth, we
used a Gaussian error structure to avoid having to remove the
informative negative values. Ideally, we would have fitted a 2-
stage Hurdle model to such data, simultaneously modeling the
factors influencing the probability of Bd growth facilitation, and
the magnitude of Bd inhibition | a positive inhibition value.
However, these models were regrettably too complex for this
dataset as the negative values were sparse and clustered within
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certain Bd isolates. Using a Gaussian model allowed us to capture
these same patterns in a simpler model. We used the R package
pheatmap (Kolde, 2019) version 1.0.12 to visualize di erences in
Bd inhibition across all probiotics tested.
Bd Relatedness and Inhibition
To assess whether more closely related Bd isolates had more
similar inhibition profiles, we conducted a Mantel test on a
matrix of pairwise relatedness values among the six Bd isolates
for which we had genomic data, and a pairwise matrix where
each cell value represented the correlation between the inhibition
profiles for each pair of Bd isolates. To build a tree of Bd isolates,
we used hierarchical clustering of genetic distance values using
the “upgma” function in the phangorn package (Schliep, 2011;
Schliep et al., 2017) in R.
Multi-Isolate Probiotics and Broad-Spectrum Bd
Inhibition
To calculate genetic distance among bacterial isolates, we aligned
the 16S rRNA gene sequences against the SILVA v132 references
alignment (Quast et al., 2013; Yilmaz et al., 2014) using mothur
1.39.5 (Schloss et al., 2009). We used the seqinr package (Charif
and Lobry, 2007) to read the alignment into R and calculate inter-
sequence distance. To examine the e ect of mean genetic distance
among consortium members on Bd inhibition, we fitted a LMM
with Bd inhibition as a response, both Bd isolate and probiotic
genus as random intercepts, and genetic distance as a random
slope given Bd isolate (i.e., Bd-specific slopes for the e ect of
probiotic genetic distance). As so many inhibition values were
near the upper bound (100% inhibition), we logit transformed
inhibition scores after converting % scores to the scale (0,1), and
used a Gaussian error structure (Warton and Hui, 2011).
RESULTS
Patterns of Inhibition Across Consortium
Types and Bd Isolates
There was strong variation in patterns of inhibition among
both probiotic types (Figures 1A,B) and among Bd isolates
within probiotic types (Figure 1B). When controlling for the
e ects of Bd isolate identity and bacterial genus in a LMM,
single-isolate probiotics exhibited the lowest average inhibition
scores (e ect of probiotic type; 1LOO =  14.3; Figures 1A,B).
The model explained 33.1% (95% credible interval, 24.1% to
41.1%) of the variance in inhibition scores overall. Considering
only the random e ects, variance component analysis indicated
that Bd isolate explained slightly more variance than bacterial
genus [Bd mean (95% CI) = 28.4% (16.1–40.7); bacterial genus
mean = 21.1% (7.9–36.3)].
We also detected substantially lower average inhibition for
two of the nine Bd isolates (JEL423 and MG04) irrespective
of the probiotic type applied (Figure 2 and Supplementary
Figure S1). Hierarchical clustering also identified these two
Bd isolates as having divergent inhibition profiles compared to
other seven isolates (Figure 2). We found no evidence that
more closely related Bd isolates had more similar inhibition
profiles across the panel of probiotics tested (Mantel test p = 0.6;
Figures 3A,B), although the two Bd isolates most resistant
to inhibition were relatively genetically similar (both isolates
were BdGPL JEL423/MG04 with a pairwise relatedness = 0.89;
Figure 3A).
Multi-Isolate Probiotics and
Broad-Spectrum Bd Inhibition
We found that consortia containing isolates from three di erent
bacterial genera had higher average between-isolate distance
than those containing two or three bacterial isolates from the
same genus (Supplementary Figure S2). However, there was
no evidence that higher average genetic distance among isolates
in a probiotic resulted in stronger inhibition when controlling
for Bd isolate and bacterial genus [e ect of genetic distance
mean (95% CI) =  2.77 ( 10.99,5.09); 1LOO e ect of genetic
distance = 0.2; Figure 4].
Considering only consortia constructed using bacterial
isolates from a single genus, we detected no consistent e ect
of increasing probiotic complexity from one to three isolates
on overall inhibition score [e ect of number of isolates, mean
(95% CI) = 3.66 ( 0.86; 8.06); Figure 5A]. Conversely, variance
component analysis revealed strong variation among both
bacterial genera and Bd isolates in determining overall inhibition
[percentage variance explained (95% CI): Bd = 34.96 (19.3–51.3);
bacterial genus = 21.68 (2.73–44.6)]. The high variance among
Bd isolates is evidenced by three Bd isolates (JEL423, MG04,
and MG09) displaying highly unstable inhibition dynamics as
probiotic complexity increased (Figure 5A). Whereas for most
Bd isolates, increasing probiotic complexity yielded higher or
stable inhibition scores, for JEL423, MG04, MG09 the addition
of bacterial isolates appeared to cause decreases in average
inhibition for two (JEL423 and MG09) and three (MG04) of
the bacterial consortia, respectively. Consistent with this, there
was a negative correlation across all Bd isolates between the
mean inhibition and variance in inhibition across genera for
three-isolate probiotics (Spearman’s rho =  0.93, p < 0.001;
Figure 5A).
Considering only probiotics constructed using bacterial
isolates from multiple genera, in 72% of cases (26/36) the
probiotic exhibited an inhibition score that was higher than
the mean of the single-isolate inhibition scores for the isolates
that probiotic contained (Figure 5B; Wilcoxon signed rank test,
V = 514, p = 0.004). Only in 19% of cases (7/36) did the
inhibition score exceed the score of the isolate with strongest
inhibition in the probiotic (Wilcoxon signed rank rest V = 66.5,
p = 1; Figure 5B). As for single-genus triple-isolate probiotics, we
observed a negative correlation between the among-consortium
variance in inhibition and mean inhibition across the nine Bd
isolates (Spearman’s rho = 0.86, p< 0.005; Figure 5B).
DISCUSSION
Our findings have revealed consistent variation among Bd
isolates in their susceptibility to inhibition by potential bacterial
probiotics. Whilst the growth of most isolates could be
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FIGURE 1 | Raw data plots of inhibition scores split by probiotic type, grouped by (A) bacterial genus averaged over B. dendrobatidis (Bd) isolates and (B) Bd
isolates averaged over bacterial genus. Data are displayed as boxplots with raw data points overlaid. Positive values (above the dashed line) indicate inhibition of Bd
growth, whereas negative values indicate that Bd grows faster in the presence of the probiotic. There is clear variation in inhibition strength across Bd isolates and
probiotic types.
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FIGURE 2 | Heatmap of inhibition scores across nine Bd isolates for all probiotic types. Rows are ordered based on increasing probiotic complexity, from single
bacterial isolate to multi-genus triple-isolate probiotics. Probiotics are color-coded according to complexity (see “Probiotic” legend). Columns have been clustered
according to similarity of inhibition profiles among Bd isolates. Data are scaled by row to permit comparison of inhibition strength across Bd isolates for each
probiotic. Multi-isolate probiotic abbreviations: Chr, Chryseobacterium; Acin, Acinetobacter; Serr, Serratia; Sten, Stenotrophomonas.
suppressed by between 70 and 100%, two of the isolates
(JEL423 and MG04) appeared to resist inhibition irrespective
of the probiotic type being employed. Consistent with previous
research, treatments comprising just a single bacterial isolate
performed worse on average when tested across a range of Bd
isolates (Antwis et al., 2015; Muletz-Wolz et al., 2017; Antwis and
Harrison, 2018). Employing multi-isolate treatments increased
average inhibition, but contrary to expectation, increasing the
genetic diversity of the consortium did not lead to increased
inhibition values. These data have important ramifications for
our ability to design probiotics that are consistently e ective
against the diverse genetic variants of Bd encountered in nature
(Becker et al., 2017; O’Hanlon et al., 2018).
There is now growing evidence that multi-strain probiotic
consortia o er both increased inhibition potential for individual
Bd isolates (Piovia-Scott et al., 2017), and a higher probability
of e ecting broad-spectrum inhibition across multiple genomic
variants of Bd, compared to probiotics comprising only a
single bacterial isolate (Antwis and Harrison, 2018; this study).
Using probiotics containing two or more isolates impeded
Bd growth more strongly on average than single isolates.
However, unlike a previous study (Antwis and Harrison,
2018), we found no support for our prediction that more
genetically diverse probiotic consortia were more e ective at
constraining Bd growth. One explanation for this pattern is
that the e ectiveness of two-isolate consortia was already very
high because consortia were constructed from isolates known
to o er strong inhibition against one of more Bd isolates.
It follows, therefore, that when inhibition by single bacterial
isolates is weak, co-culturing genetically diverse bacteria can
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FIGURE 3 | (A) Phylogenetic tree of six sequenced Bd isolates alongside isolate-specific inhibition differential – defined as the departure from the global mean
inhibition value from a Bayesian linear mixed effects model (LMM) with a Bd random effect. Estimates are marginalized with respect to bacterial genus of probiotic
isolates. Both JEL423 and MG04 exhibit 95% credible intervals not crossing zero, indicative of lower average inhibition potential compared to other isolates. (B)
Correlation plot between the average pairwise relatedness between Bd isolates and the correlation between their inhibition scores for the panel of tested probiotics
(listed in Figure 2). A Mantel test indicated no obvious relationship between inter-isolate genetic distance and similarity of inhibition profiles (p = 0.6).
elicit much stronger inhibition (Antwis and Harrison, 2018).
However, when variance in inhibition is compressed because
average inhibition is already high, the genetic distance among
consortium members is less important in determining inhibition
strength. The corollary of this is that there will undoubtedly be
variants of Bd even more resistant to treatment with probiotics
not tested in this dataset, and in such cases where mean
growth inhibition is lower (i.e., yielding more variance in
the trait) we might expect the diversity-function relationship
to re-emerge.
Though we observed an increase in mean inhibition when
using two more bacterial isolates in a consortium, the dynamics
of change in inhibition with increasing probiotic complexity
were not uniform across isolates of Bd. For three isolates in
particular (JEL423, MG04, and MG09), increasing the species-
richness of the probiotic destabilized inhibition dynamics and
increased variance in inhibition among bacterial genera. It is
noteworthy that two of these isolates were those that were most
resistant to inhibition; we observed the same negative mean-
variance relationship for consortia comprising isolates from
three bacterial genera as we did for single-genus consortia.
Similarly, it was rare to observe inhibition values for triple
consortia that exceeded that of the strongest single isolate
inhibitor in the community, indicating no evidence for strong
synergistic e ects when co-culturing. Taken together, these
results suggest that the emergent functional properties of
these microbial communities, specifically the e cacy of the
repertoire of anti-fungal metabolites they produce when co-
cultured, vary in concert with the genotype of the pathogen.
These patterns highlight the di culties associated with predicting
microbial community dynamics and function purely from
species composition (Widder et al., 2016; Momeni et al.,
2017; see also Koskella et al., 2017). Previous work using
consortia to mitigate Bd has observed strong dominance
e ects in probiotic communities, where the species attaining
highest relative abundance following co-culture is determined
by the initial species composition (Piovia-Scott et al., 2017).
Though we did not track relative abundance of individual
community members, variation across the consortia we tested
relative to their individual isolate inhibition scores likely reflects
competition e ects driving di erentmembers of each consortium
to dominance (see Friedman et al., 2017). Clearly, increasing
probiotic complexity can modify emergent function in either
a beneficial or a detrimental way, depending on the Bd
isolate used in the challenge. Therefore, the outcome of the
competition changes with total community complexity (e.g.,
Piovia-Scott et al., 2017), which in turn modifies the utility
of the consortium to depress Bd growth. Elucidating these
complex relationships between microbial community diversity-
function and pathogen genotype forms a critical component
of our understanding of how to develop probiotics with
maximum e ectiveness in the face of enormous pathogen
genomic variation. More broadly, it highlights the utility
of the bacteria-Bd system for answering general questions
about how community function scales with complexity in
microbial assemblages.
We found no evidence that genetic similarity of Bd isolates
predicted similarity of inhibition scores across the six isolates
for which there were genomic data, comprising five BdGPL
isolates and one BdCAPE. Muletz-Wolz et al. (2017) found
that the inhibition profiles of eight Bd isolates clustered by
phylogenetic relatedness, but tested a much larger phylogenetic
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FIGURE 4 | Relationship between average genetic distance of members of a multi-isolate probiotic (2 isolates or more) and inhibition of Bd, split by Bd isolate
identity. There was no evidence of a relationship between genetic distance and inhibition when controlling for probiotic ID, bacterial genus and Bd isolate identity.
A linear trend line is provided for illustration.
breath of isolates including B. salimandrivorans (Bsal) and
B. dendrobatidis-Brazil, which clustered together and separately
from six BdGPL isolates. We detected no such distinction
in our panel of Bds, where we might have expected the
BdCAPE lineage to cluster independently of isolates belonging
to BdGPL. Whilst our data do not support a linear trend
between relatedness and inhibition, we cannot discount the
possibility that there may be clusters of resistant Bd genotypes
throughout the broader Bd phylogeny. Bd can rapidly evolve
resistance to inhibition by antimicrobial peptides through
changes in genomic traits such as chromosomal copy number
(Farrer et al., 2013), and the presence of two inhibition-
resistant isolates in our dataset may reflect prior selection
against constraint of their growth by bacterial metabolites.
Future work should seek to quantify susceptibility to inhibition
over a much broader repertoire of Bd lineages, including Bsal,
to test this possibility. It would be particularly interesting to
investigate whether clusters of inhibition-resistant genotypes
cluster spatially and/or align with particular environmental
conditions. Recent in vitro work has highlighted that abiotic
conditions such as temperature can both a ect the e cacy
of bacterial probiotics against Bd (Muletz-Wolz et al., 2017)
and virulence traits of the pathogen such as growth rate
of zoosporangia (Muletz-Wolz et al., 2019). These studies
suggest that although we have achieved relatively consistent
inhibition across multiple pathogen genomic variants in
this study under controlled laboratory conditions, the true
emergent properties of probiotics in nature will instead
be function of pathogen genome, probiotic genome(s), and
environment interactions (GxGxE), which makes predicting
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FIGURE 5 | (A) Inhibition scores for single-genus probiotics of increasing complexity from single to three-isolate consortia, split by Bd isolate. (B) Inhibition scores for
three-member probiotic consortia containing isolates from three different bacteria genera. Solid circles indicate the inhibition score for a consortium for each Bd.
Smaller shapes show the individual inhibition scores of the three single isolates that comprise each consortium, with shape corresponding to bacterial isolate genus.
inhibition strength of these probiotics for novel Bd genotypes
even more challenging.
In our study, we filtered metabolites derived from bacterial co-
culture to be used in inhibition challenges against Bd. Though
challenges of this nature provide compelling evidence of the
ability of certain bacterially derived metabolites to prevent
Bd growth, they are not necessarily accurate reflections of
natural interactions among host-associated microbes, or between
microbes and the pathogen. For example, the phenotypic traits
of bacteria grown in planktonic form, as we have cultured
them, can di er vastly from those same bacteria grown in
biofilms (e.g., San-Wong et al., 2015). Likewise, our assays
prevent us from quantifying how the strength of bacteria-Bd
interactions may be modified by presence of physical contact
between cells of the resident bacteria and the pathogen. One
way to overcome these limitations for future work would
be to use a biolfilm model of infection, which is ideally
suited to studying both polymicrobial dynamics and pathogen
interactions (Gabrilska and Rumbaugh, 2015). Such assays would
provide more accurate estimates of competition and growth
processes within bacterial communities, and permit physical
interaction between bacterial biofilms and Bd. Concordant with
our results, Piovia-Scott et al. (2017) used a biofilm model
to demonstrate that the strength of inhibition of Bd is a
function of increased bacterial community complexity (see
also Antwis and Harrison, 2018). Future work should seek
to quantify the metabolic phenotype of bacteria grown in
biofilm conditions to identify the functional mechanism by
which host-associated microbes can mitigate the proliferation of
the pathogen.
In summary, developing e ective probiotic strategies to
mitigate wildlife disease is clearly complicated by the ability
of the pathogen to evolve resistance to potential probiotics
(Farrer et al., 2013), the modulation of pathogen virulence
and probiotic e ectiveness by abiotic conditions (Muletz-Wolz
et al., 2017, 2019), and the ability of the pathogen to generate
novel, potentially more virulent genotypes through hybridization
(Greenspan et al., 2018). Understanding the interplay between
pathogen genomics and local environment in determining
pathogen virulence, and the ability to dampen virulence traits
with probiotics, remains a major research priority.
DATA AVAILABILITY STATEMENT
All code and data to reproduce the results in this manuscript are
available on Figshare at DOI https://doi.org/10.6084/m9.figshare.
c.4666922.
Frontiers in Microbiology | www.frontiersin.org 9 January 2020 | Volume 10 | Article 3134
fmicb-10-03134 January 13, 2020 Time: 18:31 # 10
Harrison et al. Probiotic Strategies for Batrachochytrium dendrobatdis
ETHICS STATEMENT
The animal study was reviewed and approved by the University
of Salford Ethical Approval Committee.
AUTHOR CONTRIBUTIONS
RA and XH conceived the study and wrote the manuscript with
input from all authors. RA collected the bacterial inhibition
data. TS and MF sequenced the Bd isolates and calculated Bd
relatedness data. XH analyzed the data.
FUNDING
This study was funded by the University of Salford
Research Pump Priming Fund awarded to RA. XH
was funded by an Institute of Zoology Research
Fellowship. MF and TS were supported by NERC grant
NE/S000844/1.
ACKNOWLEDGMENTS
The authors would like to thank Prof. Ché Weldon and Prof.
Trenton Garner for access to Batrachochytrium dendrobatidis
isolates used in this study. MF is a fellow on the CIFAR ‘Fungal
Kingdom’ program.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2019.03134/full#supplementary-material
REFERENCES
Antwis, R. E., and Harrison, X. A. (2018). Probiotic consortia are not uniformly
e ective against di erent amphibian chytrid pathogen isolates. Mol. Ecol. 27,
577–589. doi: 10.1111/mec.14456
Antwis, R. E., Preziosi, R. F., Harrison, X. A., and Garner, T. W. (2015). Amphibian
symbiotic bacteria do not show a universal ability to inhibit growth of the global
panzootic lineage of Batrachochytrium dendrobatidis. Appl. Environ. Microbiol.
81, 3706–3711. doi: 10.1128/aem.00010-15
Antwis, R. E., and Weldon, C. (2017). Amphibian skin defences show variation in
ability to inhibit growth of Batrachochytrium dendrobatidis isolates from the
Global Panzootic Lineage. Microbiology 163, 1835–1838. doi: 10.1099/mic.0.
000570
Becker, C. G., Greenspan, S. E., Tracy, K. E., Dash, J. A., Lambertini, C., Jenkinson,
T. S., et al. (2017). Variation in phenotype and virulence among enzootic and
panzootic amphibian chytrid lineages. Fungal Ecol. 26, 45–50. doi: 10.1016/j.
funeco.2016.11.007
Bell, S. C., Alford, R. A., Garland, S., Padilla, G., and Thomas, A. D. (2013).
Screening bacterial metabolites for inhibitory e ects against Batrachochytrium
dendrobatidis using a spectrophotometric assay.Dis. Aquat. Organ. 103, 77–85.
doi: 10.3354/dao02560
Brophy, C., Dooley, Á, Kirwan, L., Finn, J. A., McDonnell, J., Bell, T., et al.
(2017). Biodiversity and ecosystem function: making sense of numerous species
interactions inmulti-species communities. Ecology 98, 1771–1778. doi: 10.1002/
ecy.1872
Bürkner, P. (2018). Advanced bayesian multilevel modeling with the R package
brms. R J. 10, 395–411. doi: 10.32614/RJ-2018-2017
Bürkner, P. C. (2017). brms: an R package for bayesian multilevel models using
stan. J. Stat. Softw. 80, 1–28. doi: 10.18637/jss.v080.i01
Charif, D., and Lobry, J. R. (2007). “SeqinR 1.0-2: a contributed package to the
R project for statistical computing devoted to biological sequences retrieval
and analysis,” in Structural Approaches to Sequence Evolution, eds E. Roman,
and U. Bastolla, (Berlin: Springer), 207–232. doi: 10.1007/978-3-540-353
06-5_10
Farrer, R. A., Henk, D. A., Garner, T. W., Balloux, F., Woodhams, D. C., and Fisher,
M. C. (2013). Chromosomal copy number variation, selection and uneven rates
of recombination reveal cryptic genome diversity linked to pathogenicity. PLoS
Genet. 9:e1003703. doi: 10.1371/journal.pgen.1003703
Friedman, J., Higgins, L. M., and Gore, J. (2017). Community structure follows
simple assembly rules in microbial microcosms. Nat. Ecol. Evol. 1:0109. doi:
10.1038/s41559-017-0109
Gabrilska, R. A., and Rumbaugh, K. P. (2015). Biofilm models of
polymicrobial infection. Future Microbiol. 10, 1997–2015. doi: 10.2217/fmb.
15.109
Greenspan, S. E., Lambertini, C., Carvalho, T., James, T. Y., Toledo, L. F., Haddad,
C. F., et al. (2018). Hybrids of amphibian chytrid show high virulence in native
hosts. Sci. Rep. 8:9600. doi: 10.1038/s41598-018-27828-w
Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L.,
et al. (2008). Global trends in emerging infectious diseases. Nature 451:990.
doi: 10.1038/nature06536
Kerry, R. G., Patra, J. K., Gouda, S., Park, Y., Shin, H. S., and Das, G. (2018).
Benefaction of probiotics for human health: a review. J. Food Drug Anal. 26,
927–939. doi: 10.1016/j.jfda.2018.01.002
Kolde R. (2019). pheatmap: Pretty Heatmaps. R Package Version 1.0.12. Available
at: https://CRAN.R-project.org/package=pheatmap (accessed May 2019).
Koskella, B., Hall, L. J., and Metcalf, C. J. (2017). The microbiome beyond the
horizon of ecological and evolutionary theory. Nat. Ecol. Evol. 1:1606. doi:
10.1038/s41559-017-0340-2
Kueneman, J. G., Woodhams, D. C., Harris, R., Archer, H. M., Knight, R., and
McKenzie, V. J. (2016). Probiotic treatment restores protection against lethal
fungal infection lost during amphibian captivity. Proc. R. Soc. B 283:20161553.
doi: 10.1098/rspb.2016.1553
Lips, K. R. (2016). Overview of chytrid emergence and impacts on
amphibians. Philos. Trans. R. Soc. B 371:20150465. doi: 10.1098/rstb.2015.
0465
Longo, A. V., Fleischer, A. C., and Lips, K. R. (2019). Double trouble: co-infections
of chytrid fungi will severely impact widely distributed newts. Biol. Invas. 21,
2233–2245. doi: 10.1007/s10530-019-01973-3
Marcano, I. E., Díaz-Alcántara, C. A., Urbano, B., and González-Andrés, F. (2016).
Assessment of bacterial populations associated with banana tree roots and
development of successful plant probiotics for banana crop. Soil Biol. Biochem.
99, 1–20. doi: 10.1016/j.soilbio.2016.04.013
McKenzie, V. J., Kueneman, J. G., and Harris, R. N. (2018). Probiotics as
a tool for disease mitigation in wildlife: insights from food production
and medicine. Ann. N. Y. Acad. Sci. 1429, 18–30. doi: 10.1111/nyas.
13617
Mingmongkolchai, S., and Panbangred, W. (2018). Bacillus probiotics: an
alternative to antibiotics for livestock production. J. Appl. Microbiol. 124,
1334–1346. doi: 10.1111/jam.13690
Momeni, B., Xie, L., and Shou, W. (2017). Lotka-Volterra pairwise modeling fails
to capture diverse pairwise microbial interactions. eLife 6:e25051. doi: 10.7554/
eLife.25051
Muletz-Wolz, C. R., Almario, J. G., Barnett, S. E., DiRenzo, G. V., Martel, A.,
Pasmans, F., et al. (2017). Inhibition of fungal pathogens across genotypes
and temperatures by amphibian skin bacteria. Front. Microbiol. 8:1551. doi:
10.3389/fmicb.2017.01551
Muletz-Wolz, C. R., Barnett, S. E., DiRenzo, G. V., Zamudio, K. R., Toledo, L. F.,
James, T. Y., et al. (2019). Diverse genotypes of the amphibian-killing fungus
Frontiers in Microbiology | www.frontiersin.org 10 January 2020 | Volume 10 | Article 3134
fmicb-10-03134 January 13, 2020 Time: 18:31 # 11
Harrison et al. Probiotic Strategies for Batrachochytrium dendrobatdis
produce distinct phenotypes through plastic responses to temperature. J. Evol.
Biol. 32, 287–298. doi: 10.1111/jeb.13413
O’Hanlon, S. J., Rieux, A., Farrer, R. A., Rosa, G. M., Waldman, B., Bataille, A., et al.
(2018). Recent Asian origin of chytrid fungi causing global amphibian declines.
Science 360, 621–627. doi: 10.1126/science.aar1965
Piovia-Scott, J., Rejmanek, D., Woodhams, D. C., Worth, S. J., Kenny, H.,
McKenzie, V., et al. (2017). Greater species richness of bacterial skin
symbionts better suppresses the amphibian fungal pathogen Batrachochytrium
dendrobatidis.Microb. Ecol. 74, 217–226. doi: 10.1007/s00248-016-0916-4
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., et al. (2013).
The SILVA ribosomal RNA gene database project: improved data processing
and web-based tools. Opens external link in new window.Nucleic Acids Res. 41,
D590–D596. doi: 10.1093/nar/gks1219
R Core Team (2019). R: A Language and Environment for Statistical Computing.
Vienna: R Foundation for Statistical Computing.
San-Wong, H., Maker, G. L., Trengove, R. D., andO’Handley, R.M. (2015). GCMS-
based metabolite profiling of Salmonella typhimurium di erentiates between
biofilm and planktonic phenotypes. Appl. Environ. Microbiol. 81, 2660–2666.
doi: 10.1128/AEM.03658-14
Scheele, B. C., Pasmans, F., Skerratt, L. F., Berger, L., Martel, A., Beukema,
W., et al. (2019). Amphibian fungal panzootic causes catastrophic and
ongoing loss of biodiversity. Science 363, 1459–1463. doi: 10.1126/science.aav
0379
Schliep, K., Potts, A. J., Morrison, D. A., and Grimm, G. W. (2017). Intertwining
phylogenetic trees and networks. Methods Ecol. Evol. 8, 1212–1220. doi: 10.
1111/2041-210x.12760
Schliep, K. P. (2011). phangorn: phylogenetic analysis in R. Bioinformatics 27,
592–593. doi: 10.1093/bioinformatics/btq706
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister,
E. B., et al. (2009). Introducing mothur: open-source, platform-independent,
community-supported software for describing and comparing microbial
communities. Appl. Environ. Microbiol. 75, 7537–7541. doi: 10.1128/AEM.
01541-09
Tan, L. T., Chan, K. G., Lee, L. H., and Goh, B. H. (2016). Streptomyces bacteria as
potential probiotics in aquaculture. Front. Microbiol. 7:79. doi: 10.3389/fmicb.
2016.00079
Tompkins, D. M., Carver, S., Jones, M. E., Krko ek, M., and Skerratt, L. F. (2015).
Emerging infectious diseases of wildlife: a critical perspective. Trends Parasitol.
31, 149–159. doi: 10.1016/j.pt.2015.01.007
Vehtari, A., Gabry, J., Yao, Y., and Gelman, A. (2019). loo: E cient Leave-One-
Out Cross-Validation and WAIC for Bayesian Models. R Package Version 2.1.0.
Available at: https://CRAN.R-project.org/package=loo (accessed May 2019).
Vehtari, A., Gelman, A., and Gabry, J. (2017). Practical Bayesian model evaluation
using leave-one-out cross-validation and WAIC. Stat. Comput. 27, 1413–1432.
doi: 10.1007/s11222-016-9696-4
Warton, D. I., and Hui, F. K. (2011). The arcsine is asinine: the analysis of
proportions in ecology. Ecology 92, 3–10. doi: 10.1890/10-0340.1
Widder, S., Allen, R. J., Pfei er, T., Curtis, T. P., Wiuf, C., Sloan, W. T., et al.
(2016). Challenges in microbial ecology: building predictive understanding of
community function and dynamics. ISME J. 10:2557. doi: 10.1038/ismej.2016.
45
Yilmaz, P., Parfrey, L. W., Yarza, P., Gerken, J., Pruesse, E., Quast, C., et al. (2014).
The SILVA and "All-species Living Tree Project (LTP)" taxonomic frameworks.
Opens external link in new window. Nucl. Acids Res. 42, D643–D648. doi:
10.1093/nar/gkt1209
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Harrison, Sewell, Fisher and Antwis. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 11 January 2020 | Volume 10 | Article 3134
